ENDV 10-K 12/31/15

Company

ENDONOVO THERAPEUTICS, INC.

Filed

April 5, 2016

Period of Report

December 31, 2015

Accession Number

0001469709-16-000755

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →